Description

This fund aims to achieve its investment objective by typically allocating a minimum of 80% of its net assets (plus any capital borrowed for investment purposes) to companies that the portfolio manager believes exhibit a life science orientation. As a fundamental principle guiding its pursuit of life science-focused companies, the fund also has a policy to normally invest at least 25% of its total holdings in businesses formally classified within the "life sciences" sector.